Peer Support Program in Chronic Kidney Patient
Examining the Effect of the Peer Support Program Applied to Chronic Kidney Patients on Care Outcomes
1 other identifier
interventional
50
1 country
1
Brief Summary
The main advantage of patient-to-patient peer counseling is that it benefits both the client and the peer mentors as real and authentic experiences are shared. Since both individuals go through similar experiences, they can share common feelings. Although there are studies in the literature showing the effectiveness of peer support groups in different patient groups, studies on chronic kidney disease patients are limited. There are no studies on the effects of these programs on caregivers. This study will be conducted to examine the effects of peer support program applied to chronic kidney patients on patient outcomes and caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2024
CompletedFirst Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2025
CompletedAugust 15, 2024
August 1, 2024
7 months
July 30, 2024
August 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adaptation to the disease.
"End Stage Renal Disease Adaptation Questionnaire (ESRD-AQ)" Total score varies between 0 and 1200. As the score obtained from the scale increases, the level of treatment compliance increases.
The scale will be completed before the intervention and at 3, 7 and 9 weeks.
Secondary Outcomes (1)
Self-Care
The scale will be completed before the intervention and at 3, 7 and 9 weeks.
Other Outcomes (2)
Patient outcomes
The Kt/V value of all patients calculated before the intervention and the change in the value measured 3, 7 and 9 weeks after the intervention will be completed by the researcher.
Caregivers on Care Burden
The scale will be completed by the patients before the intervention and at 9th week.
Study Arms (2)
Intervention group (Peer support)
OTHER"Peer mentors" will be determined among the participant patients in accordance with the peer mentor guide selection criteria. The determined peer mentors will participate in the "Peer Mentor Training Programme". Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution. The data collection forms used in the research process will be collected at the stages specified in the study flow plan and data entry will be made by the researcher.
Control group (Standart care)
OTHERNo intervention will be made by the researcher to the control group. The standard care of the institution will be applied to the patients.
Interventions
Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan. Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution.
The standard care provided by the institution will continue.
Eligibility Criteria
You may not qualify if:
- Speaking Turkish
- To be literate
- CKD receiving haemodialysis
- Volunteering
- years of age or older
- Being open to communication and co-operation
- Not having any psychiatric disorder
- Speaking Turkish
- To be literate
- CKD receiving haemodialysis
- Volunteering
- years of age or older
- Not having any psychiatric disorder
- Being under 18 years of age
- Speaking a language other than Turkish
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Canan Yüksel Acar
Istanbul, 34752, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Canan Yüksel Acar, Msc
Acibadem Universty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Intervation group (Peer support) Control group (Standart care)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 15, 2024
Study Start
January 11, 2024
Primary Completion
July 26, 2024
Study Completion
January 30, 2025
Last Updated
August 15, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share